Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease

BACKGROUND: Preventing postoperative recurrence (POR) is a major concern in Crohn's disease (CD). While azathioprine is an option, no data is available on ustekinumab efficacy in this situation. AIMS: We compared the effectiveness of ustekinumab versus azathioprine in preventing endoscopic POR...

Descripción completa

Detalles Bibliográficos
Autores principales: Buisson, Anthony, Nancey, Stéphane, Manlay, Luc, Rubin, David T, Hebuterne, Xavier, Pariente, Benjamin, Fumery, Mathurin, Laharie, David, Roblin, Xavier, Bommelaer, Gilles, Pereira, Bruno, Peyrin‐Biroulet, Laurent, Vuitton, Lucine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259431/
https://www.ncbi.nlm.nih.gov/pubmed/33951350
http://dx.doi.org/10.1002/ueg2.12068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259431/
https://www.ncbi.nlm.nih.gov/pubmed/33951350
http://dx.doi.org/10.1002/ueg2.12068

Ejemplares similares